Skip to main content
. 2019 Jul 26;52(1):292–300. doi: 10.4143/crt.2019.186

Fig. 1.

Fig. 1.

Progression-free survival (PFS) and overall survival (OS) of human epidermal growth factor receptor 2 (HER2)-altered non-small cell lung cancer patients.